Canopy Growth (CGC) Change in Receivables (2019 - 2025)
Canopy Growth's (CGC) quarterly Change in Receivables came in at $4.1 million in Q4 2025, down 18.0% year-on-year from $5.1 million in Q4 2024, and up 125.37% quarter-over-quarter from -$16.3 million in Q3 2025.
Canopy Growth (CGC) Change in Receivables (2019 - 2025) Analysis & Trends
Canopy Growth has disclosed Change in Receivables across 7 years of filings, most recently posting $4.1 million for Q4 2025.
- Change in Receivables for Q4 2025 came in at $4.1 million, down 18.0% year-over-year; the trailing twelve-month figure through Dec 2025 was -$13.4 million (down 132.44% YoY), and the FY2025 annual result was $3.1 million, up 12.35% from the prior year.
- Change in Receivables came in at $4.1 million for Q4 2025 at Canopy Growth, up from -$16.3 million in the prior quarter.
- In the past five years, Change in Receivables ranged from a high of $15.2 million in Q2 2023 to a low of -$16.3 million in Q3 2025.
- The 5-year median for Change in Receivables is -$628391.5 (2024), against an average of -$1.3 million.
- Across the five-year window, Change in Receivables tumbled 2250.97% in 2022 and soared 612.35% in 2023, its largest moves.
- Canopy Growth's Change in Receivables stood at $6.6 million in 2021, then tumbled by 111.71% to -$768381.2 in 2022, then jumped by 248.84% to $1.1 million in 2023, then surged by 341.59% to $5.1 million in 2024, then retreated by 18.0% to $4.1 million in 2025.
- The last three Change in Receivables figures came in at $4.1 million (Q4 2025), -$16.3 million (Q3 2025), and -$2.1 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -78.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 106.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -38.20 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 81.40 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 23.22 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 116.25 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 2.23 Mn |
| 10 | Canopy Growth | 11.38 Mn | -137.31 Mn | 15.39 Mn | 4.14 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 4.14 Mn |
| Dec 31, 2025 | 4.14 Mn |
| Sep 30, 2025 | -16.32 Mn |
| Sep 30, 2025 | -16.32 Mn |
| Jun 30, 2025 | -2.10 Mn |
| Jun 30, 2025 | -2.10 Mn |
| Mar 31, 2025 | 921,323.58 |
| Mar 31, 2025 | 921,323.58 |
| Dec 31, 2024 | 5.05 Mn |
| Dec 31, 2024 | 5.05 Mn |
| Sep 30, 2024 | -2.36 Mn |
| Sep 30, 2024 | -2.36 Mn |
| Jun 30, 2024 | -488,401.89 |
| Jun 30, 2024 | -488,401.89 |
| Mar 31, 2024 | -7.95 Mn |
| Mar 31, 2024 | -7.95 Mn |
| Dec 31, 2023 | 1.14 Mn |
| Dec 31, 2023 | 1.14 Mn |
| Sep 30, 2023 | -5.60 Mn |
| Sep 30, 2023 | -5.60 Mn |